Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.69ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.69NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.26ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
ER.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
ER.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ER.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ER.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.640ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.640ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.640ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.640NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BA.1.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.43.6 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.43.6 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.43.6 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.6 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBF.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBF.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.43.9 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.43.9 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.43.9 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.9 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XUORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XUENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XUENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XUNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.3 (Omicron)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.3 (Omicron)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.3 (Omicron)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used